Since tocilizumab, a humanized anti-interleukin (IL)-6 receptor antibody, and tumor necrosis factor (TNF) inhibitors have become available as standard treatment for RA, AA amyloidosis is now a treatable and preventable disease [2]. The gene discussed is TNF; the disease is AA amyloidosis.